In telecommunication, the term facility has the following meanings:

1. A fixed, mobile, or transportable structure, including (a) all installed electrical and electronic wiring, cabling, and equipment and (b) all supporting structures, such as utility, ground network, and electrical supporting structures.

2. A network-provided service to users or the network operating administration.

More on [ Telecommunications facility ]

Parkinson's Disease News From Medical News Today

Parkinson's Disease Alters Patient's Ability To Learn From Rewards While Treatment Affects Ability To Learn From Negative Outcomes
Thu, 02 Jul 2009 00:00:00 -0700
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make. The test was developed by Dr. Mark Gluck, professor of neuroscience at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark, working with co-researchers at Rutgers, New York University, and in Hungary.
Discovery Of Neural Stem Cell Differentiation Factor
Wed, 01 Jul 2009 05:00:00 -0700
Neural stem cells represent the cellular backup of our brain. These cells are capable of self-renewal to form new stem cells or differentiate into neurons, astrocytes or oligodendrocytes. Astrocytes have supportive functions in the environment of neurons, while oligodendrocytes form the myelin layer around axons in order to accelerate neuronal signal transmission.
Neupro(R) (rotigotine Transdermal Patch) Can Now Be Prescribed To All Patients With Idiopathic Parkinson's Disease In Europe
Tue, 30 Jun 2009 00:00:00 -0700
UCB announced that Neupro(R) (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009.
UCB Brings Neupro(R) Back To All Patients In Europe
Mon, 29 Jun 2009 04:00:00 -0700
UCB announced that Neupro® (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009.
European Scientific Committee Positive Recommendation From For A New Once Daily Mirapexin(R) Formulation For The Treatment Of Parkinson's Disease
Sun, 28 Jun 2009 01:00:00 -0700
Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin®/ Sifrol® (pramipexole), in all countries of the European Union, Norway, Iceland and Liechtenstein.
UT Gets Federal Stimulus Grant For Parkinson's Disease Research
Sun, 28 Jun 2009 00:00:00 -0700
The University of Texas Health Science Center at Houston has received a $412,500 federal stimulus grant for Parkinson's disease research, the university announced today. It is the university's first federal stimulus grant. Parkinson's disease is an incurable brain disorder. Its symptoms include trembling, stiffness and problems with balance. An estimated one million Americans are diagnosed with the neurological disorder.

Subscribe to Senior_Health RSS feed